MET融合和拼接变体是天体细胞瘤,异酸盐脱酶突变的强烈不良预后因素
Lingyu Liu1, Ke-Nan Zhang1, Zheng Zhao1
1Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
Brain pathology (Zurich, Switzerland)
|August 2, 2023
概括
MET融合和拼接变异表明异酸脱酶突变天体细胞瘤的预后不佳. 这些MET变化可以作为高度异酸脱酶突变天体细胞瘤的诊断生物标志物.
科学领域:
- 神经瘤学神经瘤学
- 分子诊断学 分子诊断学
- 癌症遗传学 癌症遗传学
背景情况:
- 星细胞瘤,异酸脱酶 (IDH) 突变,是一种具有可变预后的初级脑瘤.
- 确定可靠的生物标志物对于准确的诊断和治疗分层至关重要.
- 在IDH突变天体细胞瘤中,特定遗传变化的作用,如MET变化,需要进一步阐明.
研究的目的:
- 研究IDH突变天体细胞瘤中MET融合和拼接变异的预后意义.
- 评估MET变化的潜力,作为高度IDH突变天体细胞瘤的诊断生物标志物.
主要方法:
- 对IDH突变天体细胞瘤患者数据的回顾性分析.
- 分子分析以检测MET融合和拼接变体.
- MET改变状态与临床结果和瘤等级的相关性.
主要成果:
- 发现MET融合和拼接变体具有不利的预后作用.
- 这些MET变化的存在与IDH突变天体细胞瘤的较差结果有关.
- 转基因变化显示出潜在的高度疾病指标.
结论:
- MET融合和拼接变体与IDH突变天体细胞瘤的不良预后有关.
- 这些MET变化代表了高度IDH突变天体细胞瘤的潜在诊断生物标志物.
- 需要进一步的研究来验证这些发现,并探索治疗影响.
相关概念视频
Induced Pluripotent Stem Cells
4.2K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.2K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
RNA Splicing
56.5K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.5K


